Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma of the Prostate Stage II”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02217709
What this trial is testing

Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
University of Southern California 26
Large-scale testing (Phase 3)Study completedNCT00002511
What this trial is testing

Radiation Therapy Compared With No Further Treatment Following Surgery in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,005
Testing effectiveness (Phase 2)UnknownNCT00024414
What this trial is testing

DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Theradex
Testing effectiveness (Phase 2)Ended earlyNCT00003516
What this trial is testing

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
Burzynski Research Institute 16
Not applicableStudy completedNCT00336934
What this trial is testing

Pomegranate Extract in Treating Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiation Therapy for Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Roll International Corporation 183
Testing effectiveness (Phase 2)Study completedNCT00276549
What this trial is testing

Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 35
Not applicableEnded earlyNCT01045226
What this trial is testing

Proton Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Abramson Cancer Center at Penn Medicine 300
Testing effectiveness (Phase 2)Study completedNCT00003312
What this trial is testing

Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 95
Large-scale testing (Phase 3)Study completedNCT00030654
What this trial is testing

Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 21
Early research (Phase 1)Study completedNCT00002480
What this trial is testing

Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT00258466
What this trial is testing

Radiation Therapy in Treating Patients With Stage I, Stage II, or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Not applicableStudy completedNCT01664130
What this trial is testing

High-Dose Stereotactic Radiation for Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage I Prostate Cancer+3 more
Case Comprehensive Cancer Center 35
Testing effectiveness (Phase 2)Study completedNCT01807065
What this trial is testing

Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateBone MetastasesHormone-resistant Prostate Cancer+3 more
City of Hope Medical Center 51
Very early researchLooking for participantsNCT05852041
What this trial is testing

RhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+1 more
Northwestern University 40
Testing effectiveness (Phase 2)Study completedNCT00311623
What this trial is testing

Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32
Testing effectiveness (Phase 2)Study completedNCT02326805
What this trial is testing

PROSTVAC (PSA-TRICOM) in Preventing Disease Progression in Patients With Localized Prostate Cancer Undergoing Active Surveillance

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7
National Cancer Institute (NCI) 154
Testing effectiveness (Phase 2)Ended earlyNCT00879619
What this trial is testing

Taxotere/Prednisone Plus Sunitinib in Chemotherapy-Naïve, Hormone Refractory Prostate Cancer Patients

Who this might be right for
Prostate CancerAdenocarcinoma of the ProstateRecurrent Prostate Cancer+3 more
John P. Fruehauf 4
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Early research (Phase 1)Ended earlyNCT00023634
What this trial is testing

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Who this might be right for
Brain TumorsGastric CancerOvarian Cancer+1 more
SWOG Cancer Research Network 14
Next Page